| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.00293992674122322 | 0.11912838 |
| NSC 618296 | Null | 0.00293992674122322 | 0.4871921 |
| NSC 628121 | Null | 0.00293992674122322 | 0.36204332 |
| NSC 629749 | .beta.-Lapachone | 0.00293992674122322 | 0.19876968 |
| NSC 648365 | Insulin-Methotrexate conjugate | 0.00293992674122322 | 0.13975602 |
| NSC 676343 | Null | 0.00293992674122322 | 0.32919663 |
| NSC 679002 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- | 0.00293992674122322 | 0.12229549 |
| NSC 704888 | Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester | 0.00293992674122322 | 0.17070818 |
| NSC 711615 | Null | 0.00293992674122322 | 0.41677076 |
| NSC 723888 | 3-benzyl-2-methyl-4,5-dioxo-4,5-dihydro-3H-benzo[e]indole-1-carboxylic acid, ethyl ester | 0.00293992674122322 | 0.30451928 |